T2 Biosystems Inc reports results for the quarter ended in December - Earnings Summary

T2 Biosystems

13/03/2023 21:01

* T2 Biosystems Inc  TTOO.OQ  reported a quarterly adjusted
loss
of $1.41​​ per share for the quarter ended in December. The mean
expectation of three analysts for the quarter was for a loss of
$1.70 per share.
    * Revenue fell 21.4% to $5.48 million from a year ago;
analysts
expected $5.40 million. 
    * T2 Biosystems Inc's reported EPS for the quarter was a
loss of
$1.41​.
    * The mean earnings estimate of analysts had fallen by
about 38.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * T2 Biosystems Inc shares had fallen by 60.6% this quarter.
    * The company reported a quarterly loss of $10.41 million.
    * Wall Street's median 12-month price target for T2
Biosystems Inc
is $1.50 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 13 at 09:00 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -1.70          -1.41          Beat
 Sep. 30 2022      -2.04          -2.95          Missed
 Jun. 30 2022      -4.50          -5.00          Missed
 Mar. 31 2022      -3.75          -5.00          Missed